Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1PCAS
02 1Noramco, LLC
03 2SpecGx LLC
01 2METHYLNALTREXONE BROMIDE
02 1Methylnaltrexone Bromide
03 1Naltrexone Methobromide
01 1France
02 2Ireland
03 1U.S.A
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 10577-919
Start Marketing Date : 2024-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
NDC Package Code : 51634-3248
Start Marketing Date : 2024-07-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-0151
Start Marketing Date : 2013-12-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-1251
Start Marketing Date : 2013-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
72
PharmaCompass offers a list of Methylnaltrexone Bromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methylnaltrexone Bromide manufacturer or Methylnaltrexone Bromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methylnaltrexone Bromide manufacturer or Methylnaltrexone Bromide supplier.
PharmaCompass also assists you with knowing the Methylnaltrexone Bromide API Price utilized in the formulation of products. Methylnaltrexone Bromide API Price is not always fixed or binding as the Methylnaltrexone Bromide Price is obtained through a variety of data sources. The Methylnaltrexone Bromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Methylnaltrexone Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methylnaltrexone Bromide, including repackagers and relabelers. The FDA regulates Methylnaltrexone Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methylnaltrexone Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methylnaltrexone Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methylnaltrexone Bromide supplier is an individual or a company that provides Methylnaltrexone Bromide active pharmaceutical ingredient (API) or Methylnaltrexone Bromide finished formulations upon request. The Methylnaltrexone Bromide suppliers may include Methylnaltrexone Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Methylnaltrexone Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Methylnaltrexone Bromide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Methylnaltrexone Bromide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Methylnaltrexone Bromide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Methylnaltrexone Bromide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Methylnaltrexone Bromide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Methylnaltrexone Bromide suppliers with NDC on PharmaCompass.
We have 3 companies offering Methylnaltrexone Bromide
Get in contact with the supplier of your choice:
